Ian is an independent consultant with expertise in regulatory and scientific aspects of nicotine and tobacco products. His consulting work encompasses clinical and behavioural studies of tobacco and nicotine products for regulatory submissions in the US and Europe, and he has a wealth of experience of both consumer goods and medicinal licensing submissions. His 17 years working in the Tobacco Harm Reduction arena has included roles as Senior Director of Clinical and Regulatory Affairs EMEA with JUUL Labs, Director of Tobacco Research with Celerion, and Principal Scientist and Head of Clinical Research at British American Tobacco. As well as his consulting, Ian is a Scientific Advisory Board Member with Qnovia, a medtech startup seeking authorisation for a novel NRT in the UK and the US, and is also an Independent Non-Exec Director with Advanced Inhalation Rituals (AIR), a global shisha manufacturer.
All videos (1)
GFN.TV Interviews #84 | MYTH MACHINE | How Flawed Science Fuels Nicotine Prohibition
20 Mar 2026
Governments insist their nicotine policies are “evidence-based.” But a closer look reveals cherry-picked findings, flawed comparisons, and sensational claims that don’t withstand scrutiny. In this GFN interviews, independent tobacco scientist Dr. Ian Fearon explains how weak research and distorted interpretations shape global nicotine policy. From the misuse of correlation to media amplification of questionable studies, Fearon shows how flawed science fuels prohibitionist thinking—leaving smokers misinformed about safer alternatives that could reduce the harms of smoking.
Featuring:
DR. IAN FEARON
Director, Independent Research Scientist
whatIF? Consulting, UK